Currently predicting for Thu, 4 Jun 2026

IRWD Prediction Chart

IRWD Predictions History

Latest community submissions for IRWD.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 19, 2026 $4.64 -2.92% $4.61 V 99.34% 4
Feb 19, 2026 $4.69 -1.82% $4.61 V 98.20% 1
Feb 19, 2026 Bullish $4.61 X 0
Jan 16, 2026 $4.37 -3.33% $4.50 V 97.09% 1
Jan 16, 2026 $4.43 -2.08% $4.50 V 98.35% 1
Jan 16, 2026 $6.00 +32.74% $4.50 X 66.67% 0
Nov 24, 2025 $3.04 -3.74% $3.32 X 91.62% 0
Nov 24, 2025 $3.23 +2.34% $3.32 V 97.40% 1
Nov 24, 2025 Bullish $3.32 V 1
Oct 8, 2025 $1.57 +3.52% $1.58 V 99.59% 5
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for IRWD with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT IRONWOOD PHARMACEUTICALS
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE